Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Elmira Ebrahimi"'
Autor:
Marveh Rahmati, Elmira Ebrahimi, Reza Shirkoohi, Habibollah Mahmoodzadeh, Ahad Mohammanjad, Hedyeh Malekisarvar, Zahra Valizadeh, Marzieh Dehghani, Shirin Haghighat, Maryam Marzban, Kazem Zendehdel
Publikováno v:
Basic & Clinical Cancer Research, Vol 15, Iss 2 (2024)
Introduction: Mutations occurring in the CDH1 gene elevate the susceptibility to the development of hereditary diffuse gastric cancer (HDGC) as well as lobular breast cancer (LBC). LBCs with CDH1 germline mutations are classified as hereditary breast
Externí odkaz:
https://doaj.org/article/54ed741c31754457a085089307885c58
Autor:
Samira Molashahi, Dariush D Farhud, Mojtaba Saffari, Elmira Ebrahimi, Amirnader Emamirazavi, Reza Shirkoohi
Publikováno v:
Asian Pacific Journal of Cancer Biology, Vol 6, Iss 3, Pp 219-224 (2021)
Background: Fibroblast growth factor-10 (FGF-10) is a member of a superfamily with characteristics of epithelial cell proliferation and embryonic development and is assumed to have a role in a phenomenon called the epithelial-mesenchymal transition (
Externí odkaz:
https://doaj.org/article/8b5a2ca0f2934a2c8cf063d569aa6c25
Autor:
Elmira Ebrahimi, Reza Shirkoohi, Maryam Abiri, Solmaz Sabeghi, Kiyana Sadat Fatemi, Samira Dabagh Bagheri, Sirous Zeinali, Saeid Amanpour
Publikováno v:
Basic & Clinical Cancer Research, Vol 11, Iss 1 (2019)
Background: Pre-implantation Genetic Diagnosis (PGD) has recently been introduced as a reproductive choice for individuals who carry a disease-causing BRCA1/2 mutation. Since this technology has not yet been launched for patients at the Cancer Instit
Externí odkaz:
https://doaj.org/article/dbfbe3f5ac0045308af5bc0012d8678b
Autor:
Elmira Ebrahimi, Reza Shirkoohi
Publikováno v:
Archives of Breast Cancer (2018)
N/A
Externí odkaz:
https://doaj.org/article/da6584b7145642508836417b8ba654c0
Publikováno v:
Iranian Journal of Public Health, Vol 46, Iss 4 (2017)
Background: Exposure to endogenous hormones such as estrogen is known as a lifetime Breast Cancer (BC) risk factor. Polymorphisms in genes that are involved in the steroidogenic process, such as Cytochrome P450c17alpha (CYP17), affect individuals’
Externí odkaz:
https://doaj.org/article/ee1b107b518841a0976eacf6190a6155
Publikováno v:
Basic & Clinical Cancer Research, Vol 8, Iss 3 (2016)
Background: Epithelial-Mesenchymal Transition (EMT) is a fundamental stage in cancer metastasis and the presence of vascular invasion is a strong indication of the spread of the malignant tumor cells. Regulation of the EMT is a complex process in whi
Externí odkaz:
https://doaj.org/article/3f4911584d7b4a60b02aa1e8f6887227
Autor:
Wilfried Stücker, Hamid Khodayari, Stefaan Van Gool, Jürgen Hescheler, Habibollah Mahmoodzadeh, Miko Vesovic, Saeed Khodayari, Tomo Saric, Farimah Hadjilooei, Elmira Ebrahimi, Karim Nayernia
Publikováno v:
Cancer Immunology, Immunotherapy. 70:3369-3395
Nowadays, natural killer (NK) cell-based immunotherapy provides a practical therapeutic strategy for patients with advanced solid tumors (STs). This approach is adaptively conducted by the autologous and identical NK cells after in vitro expansion an
Autor:
Masumeh Mahmudi, Mahin Gholipour, Elisabete Weiderpass, Monireh Sadat Seyyedsalehi, Elmira Ebrahimi, Eero Pukkala, Omid Nabavian, Soudabeh Shahid-Sales, Maryam Hadji, Mahdieh Bakhshi, Roya Safari-Faramani, Abbas Rezaianzadeh, Hossein Poustchi, Azim Nejatizadeh, Paolo Boffetta, Farid Najafi, Farin Kamangar, Reza Shirkoohi, Elham Mohebbi, Afarin Rahimi-Movaghar, Kazem Zendehdel, Abdolvahab Moradi, Ali Akbar Haghdoost, Sareh Eghtesad, Hamideh Rashidian, Ali Reza Ansari Moghadam, Saideh Ahmadi-Simab, Maryam Marzban, Bayan Hosseini, Reza Alizadeh-Navaei, Ahmad Naghibzadeh-Tahami
Publikováno v:
Archives of Iranian Medicine. 24:167-176
Background: The International Agency for Research on Cancer (IARC) recently classified opium use as a Group 1 carcinogen. However, much remains to be studied on the relation between opium and cancer. We designed the Iranian Opium and Cancer (IROPICAN
Autor:
Elmira Ebrahimi, Reza Ghiasvand, Iraj Harirchi, Kazem Zendehdel, Mohammad R. Akbari, Elham Mohebbi, Erin Sellars, Reza Shirkoohi
Publikováno v:
Cancer Prevention Research. 12:763-770
Because the contribution of genetic factors to the burden of breast cancer is not well investigated in Iran, we aimed to examine the prevalence of mutations in breast cancer susceptibility genes, BRCA1/2 and PALB2, and to investigate the predictive p
Autor:
Hamid, Khodayari, Saeed, Khodayari, Elmira, Ebrahimi, Farimah, Hadjilooei, Miko, Vesovic, Habibollah, Mahmoodzadeh, Tomo, Saric, Wilfried, Stücker, Stefaan, Van Gool, Jürgen, Hescheler, Karim, Nayernia
Publikováno v:
Cancer immunology, immunotherapy : CII. 70(12)
Nowadays, natural killer (NK) cell-based immunotherapy provides a practical therapeutic strategy for patients with advanced solid tumors (STs). This approach is adaptively conducted by the autologous and identical NK cells after in vitro expansion an